Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
GH Research PLC - Ordinary Shares
(NQ:
GHRS
)
14.31
UNCHANGED
Official Closing Price
Updated: 4:15 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GH Research PLC - Ordinary Shares
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
17
18
Next >
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
September 25, 2022
Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From September 22, 2022
September 22, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10
Via
Benzinga
Psychedelic Stock Gainers And Losers From September 21, 2022
September 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32
Via
Benzinga
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today
September 20, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62
Via
Benzinga
Recap: GH Research Q2 Earnings
August 23, 2022
GH Research (NASDAQ:GHRS) reported its Q2 earnings results on Tuesday, August 23, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Psychedelic Stock Gainers And Losers From September 19, 2022
September 19, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.28% at $0.65
Via
Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
September 19, 2022
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Via
Benzinga
The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week
September 19, 2022
The cannabis sector consists of 5 distinctly different categories and they each perform quite differently.
Via
Talk Markets
8 Largest Psychedelic Stocks Continued Their Decline Last Week
September 18, 2022
The 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index were collectively down 10% in the past week. We also take a look at some therapy-clinic stocks.
Via
Talk Markets
Numinus Wellness, GH Research Among Top Psychedelic Movers Of Today
September 15, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 3.98% at $14.64
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
September 14, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 9.26% at $13.81
Via
Benzinga
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
September 12, 2022
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 44.93% at $1.00
Via
Benzinga
8 Largest Psychedelic Stocks Dropped Almost 12% This Week
September 10, 2022
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index, while they gained 18.5% in August, declined 11.6% this week. Also, a look into some clinic stocks.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From September 9, 2022
September 09, 2022
GAINERS: Allied (OTC:ALID) shares closed up 21.78% at $0.52
Via
Benzinga
Small Pharma, Seelos Therapeutics Among Top Psychedelic Movers Of Today
September 08, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 13.39% at $1.27
Via
Benzinga
Psychedelic Stock Gainers And Losers From September 7, 2022
September 07, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 5.66% at $1.12
Via
Benzinga
Psychedelic Stock Gainers And Losers From September 6, 2022
September 06, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.90% at $0.30 LOSERS:
Via
Benzinga
Most, But Not All, Psychedelics Companies Have Sufficient Liquidity
September 06, 2022
The Chart represents the liquidity positions of the 21 Psychedelic sector companies in the Viridian Value Tracker database.
Via
Benzinga
Largest Psychedelic Stocks Up In August; Up 42% Since End Of June
September 04, 2022
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index are on average UP 18.5% in August.
Via
Talk Markets
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
September 02, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.41% at $0.29
Via
Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
September 01, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 12.57% at $0.27 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From August 31, 2022
August 31, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 31.95% at $0.24
Via
Benzinga
Compass Pathways, Seelos Therapeutics Among Top Psychedelic Movers Of Today
August 30, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.83% at $1.09 LOSERS:
Via
Benzinga
7 Psychedelics Stocks to Buy for a Big Drug Boom
August 30, 2022
These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments
Via
InvestorPlace
Small Pharma, Biomind Labs Among Top Psychedelic Movers Of Today
August 29, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 27.51% at $0.18
Via
Benzinga
Largest Psychedelic Compound-Based Drug Stocks On A Roll - Up 50% Since End Of June
August 26, 2022
The Psychedelic Compounds-Based Drug Stocks Index went up 9.8% this week and is now up 49.5% since the end of June albeit down 32.6% YTD.
Via
Talk Markets
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
August 26, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 3.61% at $1.00 LOSERS:
Via
Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
August 24, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 17.87% at $1.22
Via
Benzinga
Psychedelic Stock Gainers And Losers From August 23, 2022
August 23, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 5.33% at $14.24
Via
Benzinga
GH Research Shares Q2 2022 Financial Results & Business Updates
August 23, 2022
GH Research PLC (NASDAQ: GHRS), the clinical-stage biopharma company dedicated to transforming the treatment of psychiatric and neurological disorders through 5-MeO-DMT production, provided a financial...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.